Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 May;67(5):1657-1659.
doi: 10.1002/hep.29722. Epub 2018 Apr 1.

Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists

Elliot B Tapper  1   2   3 , Rohit Loomba  4   5
Affiliations
Editorial

Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists

Elliot B Tapper et al. Hepatology. 2018 May.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. The Central Role of the Hepatologist in Coordinated Care for Nonalcoholic Fatty Liver Disease (NAFLD)
Hepatologists are uniquely positioned in the healthcare system in order to optimize the management of patients with NAFLD. In this conceptual diagram, we describe the resources needed and the relationships that should be cultivated in order to enhance clinical care for patients with NAFLD.
See this image and copyright information in PMC

Comment on

References

    1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nature Reviews Gastroenterology and Hepatology. 2013;10:686–690. - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed
    1. Parikh ND, Marrero WJ, Wang J, Steuer J, Tapper EB, Konerman M, Singal AG, et al. Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States. Hepatology. 2017 - PubMed
    1. Konerman MA, Fritze D, Weinberg RL, Sonnenday CJ, Sharma P. Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic Review. Transplantation. 2017;101:1645–1657. - PMC - PubMed
    1. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. Journal of hepatology. 2016;65:589–600. - PubMed